Compounds > glycine
Page last updated: 2024-10-18

glycine and Chronic Progressive Multiple Sclerosis

glycine has been researched along with Chronic Progressive Multiple Sclerosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options."5.72Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022)
"Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options."1.72Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report. ( Jezdimirovic, T; Ostojic, J; Ostojic, SM; Stajer, V; Zanini, D, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ostojic, SM1
Ostojic, J1
Zanini, D1
Jezdimirovic, T1
Stajer, V1

Other Studies

1 other study available for glycine and Chronic Progressive Multiple Sclerosis

ArticleYear
Guanidinoacetate-creatine in secondary progressive multiple sclerosis: a case report.
    The Journal of international medical research, 2022, Volume: 50, Issue:1

    Topics: Creatine; Female; Glycine; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis;

2022